To verify the observed effect by neutrophils toward melanoma cells, we further analyzed eleven BRAF-mutated melanoma cell lines and three nonmelanoma and non-BRAF-mutated cancer cell lines under nonadherent culture conditions in the absence or presence of neutrophils exposed to BRAF/MEK inhibition or cisplatin for 24 h. This evidence concerns the gene BRAF and cancer.